Clinical trial
An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)
NCT00652080 is registered in ClinicalTrials.gov with BPGbio as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)
- Lead sponsor
- BPGbio
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- January 31, 2010
- Enrollment
- 35 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
squamous cell carcinoma